期刊
NEUROGASTROENTEROLOGY AND MOTILITY
卷 32, 期 6, 页码 -出版社
WILEY
DOI: 10.1111/nmo.13830
关键词
H-1-NMR; fecal metabolites; irritable bowel syndrome; metabolic profiling
资金
- National Research Foundation of Korea (NRF) [NRF-2015R1A5A1008958]
- Ministry of Education [NRF-2017R1D1A1B03031924]
Background Gut microbiota are known to be closely related to irritable bowel syndrome (IBS). However, not much is known about characteristic fecal metabolic profiles of IBS. We aimed to characterize fecal metabolites in patients with IBS with predominant diarrhea (IBS-D) using H-1-nuclear magnetic resonance (H-1-NMR) spectroscopy. Methods In this study, we enrolled 29 patients diagnosed with IBS-D according to the Rome IV criteria, 22 healthy controls (HC) and 11 HC administered laxatives (HC-L) in the age group of 20-69 year. The usual diet of the patients and HC was maintained, their fecal samples were collected and investigated by NMR-based global metabolic profiling coupled with multivariate statistical analysis. Results We detected 55 metabolites in H-1-NMR spectra of fecal samples: four amines, 16 amino acids, six fatty acids, eight organic acids, three sugars, and 18 other compounds. Orthogonal partial least square-discriminant analysis derived score plots showed clear separation between the IBS-D group and the HC and HC-L groups. Among the 55 metabolites identified, we found five disease-relevant potential biomarkers distinguishing the IBS-D from the HC, namely, cadaverine, putrescine, threonine, tryptophan, and phenylalanine. Conclusions The patients with IBS-D were clearly differentiated from the HC and HC-L by fecal metabolite analysis using H-1-NMR spectroscopy, and five fecal metabolites characteristic of IBS-D were found. The findings of this study could be used to develop alternative and complementary diagnostic methods and as a source of fundamental information for developing novel therapies for IBS-D.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据